173 related articles for article (PubMed ID: 34203073)
21. Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.
Mandava H; Venkata Renuka I; Potti R; Mounica B; Kalla I
Cureus; 2024 May; 16(5):e60042. PubMed ID: 38774462
[TBL] [Abstract][Full Text] [Related]
22. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.
Jha S; Sethy M; Adhya AK
Diagn Cytopathol; 2021 Oct; 49(10):1089-1098. PubMed ID: 34289263
[TBL] [Abstract][Full Text] [Related]
23. Risk Stratification of Pleural Fluid Cytology Based on the International System for Reporting Serous Fluid Cytology in a Tertiary Care Centre.
Bharti S; Nalwa A; Elhence PA; Rao M; Bharti JN; Khera S; Vedant D; Vishwajeet V; Goel A
Acta Cytol; 2022; 66(5):449-456. PubMed ID: 35413720
[TBL] [Abstract][Full Text] [Related]
24. A single tertiary institution review of the international system for serous fluid cytopathology and the impact of cell block and ancillary studies on its performance.
Lim KH; Ahmed SS; Cheng XM; Hwang JSG; Karunanithi J; Mantoo S; Takano AM; Sultana R; Khor LY
J Am Soc Cytopathol; 2023; 12(1):48-57. PubMed ID: 36192336
[TBL] [Abstract][Full Text] [Related]
25. The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions.
Hou T; Landon G; Stewart J; Roy-Chowdhuri S
Cancer Cytopathol; 2021 Jan; 129(1):75-82. PubMed ID: 32809259
[TBL] [Abstract][Full Text] [Related]
26. The value of cytology in distinguishing malignant mesothelioma: An institutional experience of 210 cases reclassified according to the International System for Reporting Serous Fluid Cytopathology (ISRSFC).
Straccia P; Magnini D; Trisolini R; Lococo F; Chiappetta M; Cancellieri A
Cytopathology; 2022 Jan; 33(1):77-83. PubMed ID: 34046958
[TBL] [Abstract][Full Text] [Related]
27. The International System for Reporting Serous Fluid Cytopathology: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies.
Jamal FE; Vey JA; Proctor T; Ishak A; Schmitt FC; Nikas IP
Adv Anat Pathol; 2024 Jul; 31(4):256-264. PubMed ID: 38695284
[TBL] [Abstract][Full Text] [Related]
28. Application of algorithmic cytomorphological assessment and immunocytochemistry with the international system for reporting serous fluid cytopathology on pericardial fluid cytology.
Li JJX; Cheung W; Ng JKM; Tse GM
J Clin Pathol; 2023 Aug; ():. PubMed ID: 37643837
[TBL] [Abstract][Full Text] [Related]
29. Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.
Kolte S; Zaheer S; Aden D; Ranga S
Cytojournal; 2022; 19():52. PubMed ID: 36128470
[TBL] [Abstract][Full Text] [Related]
30. Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature.
Farahani SJ; Baloch Z
Diagn Cytopathol; 2019 Nov; 47(11):1145-1159. PubMed ID: 31301215
[TBL] [Abstract][Full Text] [Related]
31. The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.
Pinto D; Chandra A; Crothers BA; Kurtycz DFI; Schmitt F
J Am Soc Cytopathol; 2020; 9(6):469-477. PubMed ID: 32620534
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of International System for Reporting Serous Fluid Cytopathology: A systematic review and meta-analysis in malignancy diagnosis.
Ahuja S; Ahuja R; Pandey S; Zaheer S
Cancer Cytopathol; 2024 Apr; ():. PubMed ID: 38613789
[TBL] [Abstract][Full Text] [Related]
33. The international system for serous fluid cytopathology: Interobserver agreement.
Layfield LJ; Yang Z; Vazmitsel M; Zhang T; Esebua M; Schmidt R
Diagn Cytopathol; 2022 Jan; 50(1):3-7. PubMed ID: 34784101
[TBL] [Abstract][Full Text] [Related]
34. Root cause analysis of indeterminate diagnoses in serous fluids cytopathology.
Gokozan HN; Harbhajanka A; Lyden S; Michael CW
Diagn Cytopathol; 2021 May; 49(5):633-639. PubMed ID: 33125186
[TBL] [Abstract][Full Text] [Related]
35. Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.
Rodriguez EF; Pastorello RG; Morris P; Saieg M; Chowsilpa S; Maleki Z
Am J Clin Pathol; 2020 Aug; 154(3):394-402. PubMed ID: 32525969
[TBL] [Abstract][Full Text] [Related]
36. Review of the impact of the International System for Serous Fluid Cytopathology.
Mikou P; Pergaris A; Engels M; Chandra A
Cytopathology; 2024 Jan; 35(1):16-22. PubMed ID: 37795809
[TBL] [Abstract][Full Text] [Related]
37. [Serous fluid cytopathology: International system].
Basset C; Collin L; Vielh P; Courtade-Saïdi M;
Ann Pathol; 2023 Mar; 43(2):96-113. PubMed ID: 36907792
[TBL] [Abstract][Full Text] [Related]
38. Role of CD68 immunohistochemistry in categorizing benign nonmesothelial cell population and refining "atypical" category in serous fluid cytology.
Savari O; Jassim S; Ferrer H; Ganocy SJ; Ganesan S
Diagn Cytopathol; 2020 Dec; 48(12):1199-1204. PubMed ID: 32644272
[TBL] [Abstract][Full Text] [Related]
39. Real-World Evidence of Intra-institutional Performance Variation in Indefinite Diagnosis of Pleural Effusion Cytology.
Chen KH; Kuo CY; Chen TD
Arch Pathol Lab Med; 2023 Nov; ():. PubMed ID: 38031811
[TBL] [Abstract][Full Text] [Related]
40. RISK OF MALIGNANCY IN THYROID CYTOLOGY: THE IMPACT OF THE RECLASSIFICATION OF NONINVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP).
Ventura M; Melo M; Fernandes G; Carrilho F
Endocr Pract; 2019 Jul; 25(7):642-647. PubMed ID: 30865528
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
